US Patent Issued to Lexent Bio on Dec. 30 for "Methods of detecting tumor progression via analysis of cell-free nucleic acids" (California Inventor)

ALEXANDRIA, Va., Dec. 31 -- United States Patent no. 12,509,732, issued on Dec. 30, was assigned to Lexent Bio Inc. (Boston).

"Methods of detecting tumor progression via analysis of cell-free nucleic acids" was invented by Abhik Shah (San Francisco).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides methods of assessing tumor progression in a subject. In an aspect, a method for assessing tumor progression of a subject can comprise: measuring a count of a plurality of cell-free DNA (cfDNA) molecules at each of a plurality of genomic regions, wherein the plurality of cfDNA molecules is obtained or derived from a bodily fluid sample of the subject; processing the counts measured at ea...